AHA Scientific Sessions 2025 Abstract·3 NovProprotein Convertase Subtilisin/ Kexin Type 9 Inhibitors Improve Lipid Profile and May Stabilize Vasculopathy in Heart Transplant Recipients with Chronic Allograft Vasculopathy: A Pooled Analysis of Existing StudiesReviewInterventionsPaper